GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) are approved for type 2 diabetes and obesity, not Hashimoto's thyroiditis
Identity and purity claims apply only when supported by a certificate mapped to the lot offered for shipment.Documentation pending not released for shipment until a lot-linked certificate is verified
Animal models of colitis have demonstrated that GLP-1 receptor activation may reduce intestinal inflammation through multiple mechanisms, including modulation of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-) and interleukin-6 (IL-6), enhancement of intestinal barrier function, and reduction of oxidative stress
Biology does change and the signs are written on the skin and in the way the body feels
Set a realistic timeline Gradual and sustainable weight loss is best in any scenario, but especially during breastfeeding
by Dr Hayley Willacy, FRCGP Further reading and references Vitamin B12 deficiency in over 16s: diagnosis and management NICE guidance (March 2024) PHE